Arc Bio LLC, based in Menlo Park, CA, is a pioneering company revolutionizing microbial detection through their proprietary metagenomic Next-Generation Sequencing (mNGS) workflow and software solutions. Their turnkey Galileo ONE system offers a simple 4-step process, providing fast, precise, and cost-effective analyses for infectious disease research without the need for in-house bioinformaticians or mNGS library preparation expertise.
With Galileo ONE, labs can achieve unbiased sequencing and analysis directly from low biomass samples, such as plasma, detecting and quantifying over 6,000 microorganisms across 800 species without targeted primers or probes. Unlike targeted nucleic acid amplification tests (NAATs), Galileo ONE eliminates the enrichment step, delivering results in 30 hours or less and providing greater taxonomic resolution compared to culture methods. Arc Bio's customizable solutions allow labs to focus on the results that matter, making them a leader in metagenomics for microbial identification.
Generated from the website
